expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional nanoscaffold coated with fibronectin.
Authors
abstract
allogeneic hematopoietic stem cell transplantation is used in the treatment of patients suffering from hematologic and non-hematologic disorders, but the application is limited by the identification of a suitable donor. umbilical cord blood (ucb) is an alternative source of hematopoietic stem cell (hsc) transplantation. despite all advantages, the limited cell dose is one of the major obstacles. ex-vivo expansion of hsc is an alternative way to overcome this problem.in this study, polycaprolactone (pcl) scaffold coated with fibronectin (3d) is compared to routine cell culture system (two dimensional, 2d) used for cell culture.1×10(4) cord blood cd34+ cells isolated by macs were seeded on pcl scaffold and allowed to expand for 10 days. before and after this period, total cells, cd34(+) cells, cfc assay and cxcr4 expression were evaluated.our findings demonstrated that 3d scaffold produced a 58-fold expansion of total cells compared to 2d cultures (38-fold expansion). also cd34+ cells in 3d compare to 2d cell culture was 40-fold and 2.66 fold increased, respectively; this difference was statistically significant (p<0.05). moreover, total number of colonies in the 3d scaffold was higher than those of 2d cell culture system, but no statistically significant difference was observed. higher expression of cxcr4 in 3d compared to 2d showed better homing of cells that were cultured in 3d scaffold (p<0.05).pcl scaffold coated with fibronectin had higher number of total cells and cd34+cells than 2d routine culture system. findings revealed that 3d is a proper cell culture system for hematopoietic stem cell expansion, compared to 2d.
similar resources
Expansion of human cord blood hematopoietic stem/progenitor cells in three-dimensional Nanoscaffold coated with Fibronectin
BACKGROUND Allogeneic hematopoietic stem cell transplantation is used in the treatment of patients suffering from hematologic and non-hematologic disorders, but the application is limited by the identification of a suitable donor. Umbilical cord blood (UCB) is an alternative source of hematopoietic stem cell (HSC) transplantation. Despite all advantages, the limited cell dose is one of the maj...
full textEx Vivo Expansion of Umbilical Cord Blood Hematopoietic Stem Cells on Collagen- Fibronectin Coated Electrospun Nano Scaffold
Background and Objective: Umbilical Cord blood (UCB) hematopoietic stem cell (HSC) transplantation is a therapeutic approach for the treatment of malignant and non-malignant hematologic disorders due to ease of collection, lack of risk for donors and lower levels of infection. Moreover, it is considered a good alternative for bone marrow HSC transplantation. The main limitation of their use is ...
full textNanofiber Expansion of Umbilical Cord Blood Hematopoietic Stem Cells
Background The aim of this study was the ex vivo expansion of Umbilical Cord Blood hematopoietic stem cells on biocompatible nanofiber scaffolds. Materials and Methods CD133+ hematopoietic stem cells were separated from umbilical cord blood using MidiMacs (positive selection) system by means of monocolonal antibody CD133 (microbeads) subsequently, flowcytometry method was done to asses...
full textnanofiber expansion of umbilical cord blood hematopoietic stem cells
background the aim of this study was the ex vivo expansion of umbilical cord blood hematopoietic stem cells on biocompatible nanofiber scaffolds. materials and methods cd133+ hematopoietic stem cells were separated from umbilical cord blood using midimacs (positive selection) system by means of monocolonal antibody cd133 (microbeads) subsequently, flowcytometry method was done to assess the pur...
full textExpansion of human cord blood hematopoietic stem cells for transplantation.
A recent Science paper reported a purine derivative that expands human cord blood hematopoietic stem cells in culture (Boitano et al., 2010) by antagonizing the aryl hydrocarbon receptor. Major problems need to be overcome before ex vivo HSC expansion can be used clinically.
full textAdvances and challenges in storage, transplantation, expansion and homing of Umbilical Cord Blood Hematopoietic Stem Cells (UCB-HSCs)
Abstract Background and Objectives Umbilical cord blood hematopoietic stem cells (UCB-HSCs) have high potential capabilities in the treatment of hematological and non-hematological disorders. Awareness of biology, self-renewal, homing, expansion, storage, and transplantation can lead to optimal use of these cells. Materials and Methods In this Review article in order to investigate the adv...
full textMy Resources
Save resource for easier access later
Journal title:
international journal of hematology-oncology and stem cell researchجلد ۹، شماره ۲، صفحات ۷۲-۷۹
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023